The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACLARIS THERAPEUTICS INC COM 00461U105 3,285 1,500,000 SH   SOLE   1,500,000 0 0
ALLERGAN PLC SHS G0177J108 150,704 900,101 SH   SOLE   900,101 0 0
CHENIERE ENERGY INC COM NEW 16411R208 51,338 750,000 SH   SOLE   750,000 0 0
CYCLERION THERAPEUTICS INC COM 23255M105 17,036 1,487,874 SH   SOLE   1,487,874 0 0
EVOLUS INC COM 30052C107 1,754 120,000 SH   SOLE   120,000 0 0
FGL HLDGS ORD SHS G3402M102 25,200 3,000,000 SH   SOLE   3,000,000 0 0
FOX CORP CL A COM 35137L105 86,812 2,369,331 SH   SOLE   2,369,331 0 0
GOLDMAN SACHS GROUP INC COM 38141G104 35,562 173,811 SH   SOLE   173,811 0 0
GTT COMMUNICATIONS INC COM 362393100 22,000 1,250,000 SH   SOLE   1,250,000 0 0
IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108 54,039 4,939,541 SH   SOLE   4,939,541 0 0
LIBERTY GLOBAL PLC SHS CL C G5480U120 16,596 625,558 SH   SOLE   625,558 0 0
NAVIENT CORPORATION COM 63938C108 3,335 244,300 SH   SOLE   244,300 0 0
PG&E CORP COM 69331C108 64,176 2,800,000 SH   SOLE   2,800,000 0 0
PIONEER NAT RES CO COM 723787107 30,772 200,000 SH   SOLE   200,000 0 0
REVANCE THERAPEUTICS INC COM 761330109 597 46,000 SH   SOLE   46,000 0 0
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS 874060205 13,895 785,000 SH   SOLE   785,000 0 0
XPO LOGISTICS INC COM 983793100 52,835 913,935 SH   SOLE   913,935 0 0